Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4,6-Dichloro-N-phenyl-1,3,5-triazin-2-amine is a reactive and labile compound that has been shown to inhibit the nuclear factor kappa B (NF-κB). It is an analog of 2,4,6,-trichlorophenyl-1,3,5-triazine. 4,6-Dichloro-N-phenylsulfonyl triazin-2 amine is a chlorinated derivative of 4,6 dichloro triazin 2 amine. The chlorine atom in the molecule may be replaced with a cyanuric or chloride group. This chemical compound is used in dyestuffs and as a precursor for other chemicals. The effect varies depending on the dose administered.</p>

<p>Tert-Butyl N-benzylcarbamate is a synthetic compound that is being developed for the treatment of cancer. It is an analog of carmustine, a drug used for the treatment of brain tumors, and has been shown to be effective against cell lines in vitro. Tert-Butyl N-benzylcarbamate binds to DNA and inhibits protein synthesis, leading to cancer cell death. The drug also inhibits the growth of cancer cells by inhibiting chloride channels and blocking the influx of hydrogen chloride into cells. Tert-Butyl N-benzylcarbamate has not been tested in humans yet, but it has shown promising results in animal models.</p>

<p>Versatile small molecule scaffold</p>

<p>2,​3-​Dihydro-3-​thiopheneacetic acid 1,​1-​dioxide is a nucleophilic reagent that can be used to synthesize amides. It reacts with amines to form 2,​3-​dihydro-3-​thiophenecarboxylic acid 1,​1-diamide. Reactions of this compound with heterocycles such as pyridine and quinoline result in the formation of heterocyclic amines.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Chloromethyl cyclohexyl carbonate is a new acyclic nucleoside phosphonate that has been shown to have antiviral properties. It is active against HIV strains and inhibits the production of clotting factors. Chloromethyl cyclohexyl carbonate can be used as a drug substance for treating bowel disease, hepatitis, and cancer. It also modulates syncytial cells and heterocycles. Pharmacokinetic studies on chloromethyl cyclohexyl carbonate have shown that it has high bioavailability in the small intestine and liver after oral administration. It is metabolized by tyrosine kinase, which indicates that it may interfere with other drugs such as warfarin or phenytoin. Chloromethyl cyclohexyl carbonate has been found to be effective in treating gastritis and cancer in animal models.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Cycloheptanecarboxamide is a cellular amide that is used in the study of β-amino acids. Cycloheptanecarboxamide is a prodrug that is converted to cycloheptylamine, which has been shown to be an inhibitor of proliferation and a potent inhibitor of inflammatory diseases. Cycloheptylamine also inhibits the production of aliphatic hydrocarbons and mineralocorticoids, as well as the activation of mineralocorticoid receptors. It has been shown to be an organic solution that can be used to generate tartrate-resistant acid potassium ions (TRAP).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Amino-N-(quinolin-8-yl)acetamide is a fluorescent inorganic compound. It has been shown to have a high affinity for chloride, with nanotube structures that are able to bind the chloride ions by supramolecular interactions. This binding prevents the chloride from interacting with other biomolecules, such as proteins and DNA. The energy of this interaction can be measured using fluorophore spectroscopy, which can be used for bioassays and medical imaging. 2-Amino-N-(quinolin-8-yl)acetamide has also been shown to have an ability to interact with zinc ions (Zn2+) in electrospray experiments, resulting in the emission of fluorescence.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Ethynyl-4-methylthiazole is a cell-based kinase inhibitor that binds to the ATP binding site on the enzyme and inhibits phosphorylation. It was shown to inhibit cell growth in vitro by interfering with the production of TGF-β, activin, and other growth factors. The inhibitory activity of 2-Ethynyl-4-methylthiazole is selective for receptor kinases and is not effective against alk5 kinase. This drug has been shown to be an inhibitor of cellular growth in vitro and may be useful for the treatment of cancer.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>